Chemical Properties of 5H-Dibenz[b,f]azepine-5-carboxamide, 10,11-dihydro-10-hydroxy- (CAS 29331-92-8)

5H-Dibenz[b,f]azepine-5-carboxamide, 10,11-dihydro-10-hydroxy-

PDF Excel Molecule Calculator
InChI
InChI=1S/C15H14N2O2/c16-15(19)17-12-7-3-1-5-10(12)9-14(18)11-6-2-4-8-13(11)17/h1-8,14,18H,9H2,(H2,16,19)
InChI Key
BMPDWHIDQYTSHX-UHFFFAOYSA-N
Formula
C15H14N2O2
SMILES
NC(=O)N1c2ccccc2CC(O)c2ccccc21
Molecular Weight1
254.28
CAS
29331-92-8
Other Names
  • ALCOL RACEMO
  • 10,11-Dihydro-10-hydroxycarbamazepine
Cheméo is a service of Céondo GmbH, since 2007, we provide simulation, modelling and software development services for the industry. Do not hesitate to contact us for your projects.

Physical Properties

Property Value Unit Source
log10WS -3.75 Crippen Calculated Property
logPoct/wat 2.493 Crippen Calculated Property
McVol 191.230 ml/mol McGowan Calculated Property
Inp [2527.90; 2527.90]   Show Hide
Inp 2527.90 NIST
Inp 2527.90 NIST

Similar Compounds

Carbamazepine 10,11-epoxide. Poligodial + 3-methoxy-4,5-methylenedioxyamphetamine (R,S) adduct, # 2. Poligodial + 3-methoxy-4,5-methylenedioxyamphetamine (R,S) adduct, # 1. Mirtazapine-M (oxo-). Acetylsenecivernine. Dihydroergokryptine. Crinan-11-ol, 1,2-didehydro-3-methoxy-, (3«beta»,5«alpha»,11R,13«beta»,19«alpha»)-. [2,2'-Bimorphinan]-3,3',6,6'-tetrol, 7,7',8,8'-tetradehydro-4,5:4',5'-diepoxy-17,17'-dimethyl-, (5«alpha»,6«alpha»)-(5'«alpha»,6'«alpha»)-. Morphinan-3,6-diol, 7,8-didehydro-4,5-epoxy-17-methyl- (5«alpha»,6«alpha»)-, bis(trifluoroacetate) (ester). Triazolo[4,5-d]pyrimidin-7-ol,3h-v-, 5-amino-3-(2',3'-o-isopropylidene-beta-d-ribofuranosyl)-, 5'-diphenyl phosphate (keto form). Deserpidine. Paclitaxel. Ergotaman-3',6',18-trione, 9,10-dihydro-12'-hydroxy-2'-methyl-5'-(phenylmethyl)-, (5'«alpha»,10«alpha»)-. Ergotamine. Ergocristine.

Find more compounds similar to 5H-Dibenz[b,f]azepine-5-carboxamide, 10,11-dihydro-10-hydroxy-.

Sources

Note: Cheméo is only indexing the data, follow the source links to retrieve the latest data. The source is also providing more information like the publication year, authors and more. Take the time to validate and double check the source of the data.